Esperion Therapeutics’ Royalty Purchase Agreement with OMERS

Leila Ahmed
Tagged:

Gibson Dunn & Crutcher advised Esperion Therapeutics, Inc. on the deal.Esperion Therapeutics, Inc. (Nasdaq: ESPR) announced that it has entered into a Royalty Purchase Agreement (the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here